Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.

BACKGROUND Alzheimer's disease (AD) is the most common cause of dementia worldwide and a frequent comorbidity in idiopathic normal pressure hydrocephalus (iNPH). The presence of AD pathology is associated with worse outcomes after a shunt procedure in iNPH. Preoperative diagnosis of AD is challenging in patients with iNPH, which involves reduced concentrations of the cerebrospinal fluid (CSF) AD biomarkers. OBJECTIVE Our aim was to estimate the effect size of iNPH as a factor in CSF levels of AD biomarkers and to test if correction could be used to improve diagnostic value. METHODS Our cohort included 222 iNPH patients with data in the Kuopio NPH registry and brain biopsy and CSF samples available. We divided the patients into groups according to AD pathology per brain biopsy. For control cohorts, we had CSF samples from cognitively healthy individuals (n = 33) and patients with diagnosed AD and no iNPH (n = 39).*-31ptResults:Levels of all investigated biomarkers differed significantly between groups, with the exception of t-Tau levels between healthy individuals and iNPH patients with AD pathology. Applying a correction factor for each biomarker (0.842*Aβ 1 - 42, 0.779*t-Tau, and 0.610*P-Tau181) for the effect of iNPH yielded a sensitivity of 2.4% and specificity of 100%. The ratio of P-Tau181 to Aβ 1 - 42 was moderately effective in aiding recognition of AD pathology in iNPH patients (sensitivity 0.79, specificity 0.76, area under the curve 0.824). CONCLUSION Correcting for iNPH as a factor failed to improve diagnostic effectiveness, but the P-Tau181/Aβ 1 - 42 ratio showed some utility in the diagnosis of AD in iNPH patients.

[1]  S. Salloway,et al.  Longitudinal post-shunt outcomes in idiopathic normal pressure hydrocephalus with and without comorbid Alzheimer’s disease , 2022, Journal of the International Neuropsychological Society.

[2]  D. Farahmand,et al.  Ventricular volume in relation to lumbar CSF levels of amyloid-β 1–42, tau and phosphorylated tau in iNPH, is there a dilution effect? , 2022, Fluids and barriers of the CNS.

[3]  Mark D. Johnson,et al.  Deletions in CWH43 cause idiopathic normal pressure hydrocephalus , 2021, EMBO molecular medicine.

[4]  O. Forlenza,et al.  AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State , 2020, Journal of geriatric psychiatry and neurology.

[5]  J. Virhammar,et al.  Negative predictors of shunt surgery outcome in normal pressure hydrocephalus , 2019, Acta neurologica Scandinavica.

[6]  V. Leinonen,et al.  The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients , 2019, Fluids and Barriers of the CNS.

[7]  W. M. van der Flier,et al.  Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project , 2018, Alzheimer's & Dementia.

[8]  Naji Tabet,et al.  Slowing the progression of Alzheimer’s disease; what works? , 2015, Ageing Research Reviews.

[9]  N. Graff-Radford Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus , 2014, Neurology.

[10]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[11]  H. Soininen,et al.  CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings , 2012, Neurology.

[12]  J. Trojanowski,et al.  Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus , 2012, Fluids and Barriers of the CNS.

[13]  H. Soininen,et al.  Predicting Development of Alzheimer's Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus. , 2019, Journal of Alzheimer's disease : JAD.

[14]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[15]  N. Relkin INPH GUIDELINES , PART II DIAGNOSING IDIOPATHIC NORMAL-PRESSURE HYDROCEPHALUS , 2005 .